Hisataki T,Miyao N,Masumori N,et al.Risk factors for the development of bladder cancer after upper tract urothelial cancer[J].Urology,2000,55:663-667.
[3]
Matsui Y,Utsunomiya N,Ichioka K,et al.Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract[J].Urology,2005,65:279-283.
Tsunenori K,Shiro O,Osamu R, et al. Analysis of prognostic factors related to primary superficial bladder cancer tumor recurrence in prophylactic intravesical epirubicin therapy[J].Internation Journal of Urology,1999,6:178-183.
[6]
Hall MC,Womack S,Sagaloeskyv AI,et al.Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract:a 30-year experience in 252 patients[J].Urology,1998,52:594-601.
[7]
Simon V.Bariol,Grant D.Stewart,et al.Oncological control following laparoscopic nephroureterectomy:7-year outcome[J].The Journal of Urology,2004, 172:1805-1808.
[8]
Sakamoto N,Naito S,Kumazawa J,et al.Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors:a prospective randomized study[J].International Journal of Urology,2001,8:212-216.